Firebrick raises $510K as Philippines partner lifts stake past 10%
What's the deal? Firebrick PharmaDealroom has a profile for this one. Try Dealroom → (ASX: FRE) has raised US$473.6K (roughly $510,000) through a share placement led by its Philippines licensing partner, which has increased its holding to just over 10%. Pharma Nutria N.A. Inc.Dealroom has a profile for this one. Try Dealroom →, part of the S. V. More Group of CompaniesDealroom has a profile for this one. Try Dealroom →, put in US$408.8K; an existing sophisticated investor added the remaining US$64.7K.
The terms: The placement issues roughly 20.9 million shares at 3.5 cents each — a 21.5% premium to the 15-day volume weighted average price and a 20.7% premium to the last trade on October 9. The shares represent about 7.28% of current stock on issue, with the final tranche due by October 20.
What's the endgame? Firebrick makes Nasodine nasal and throat spray products. The funds will go toward production for US retail distribution, the launch of a new Nasodine product in Singapore, and working capital.
Why now? The raise lands two weeks after Firebrick announced plans to move Nasodine beyond online-only sales into US retail pharmacies. In late September, it said six US pharmacy chains had expressed early order intent, and it received a US$189.6K R&D tax incentive the same month.
The investor view: Albert-Jan Santillana, president and chief executive officer of the S. V. More Group of Companies, said the investment "reflects our growing confidence in Firebrick and in the long-term potential of the Nasodine franchise." Executive Chairman Peter Molloy called it "an important commercial affirmation for the Nasodine franchise."
What could go wrong? Early order intent is not revenue. Converting interest from US pharmacy chains into signed distribution agreements and sales remains the work ahead.
The signal: A partner lifting its stake to a 10% threshold — and paying a premium to market to do it — is a vote of confidence that outpaces Firebrick's prior raise. For a small-cap chasing US retail shelf space, strategic capital from a commercial ally carries weight beyond the dollar figure.
Read more: themarketfloor.news
Image credit: Generated with Gemini
